/ /

Lets Chat

The underlying, big hairy goal of eye careHow long does it actually take to form a new habit? Is there any science to back this up? And what does all of this mean for your practice?
Retina surgeon’s AMD regimen at center of Medicare fraud case
Retina surgeon’s AMD regimen at center of Medicare fraud caseEarlier this month, a jury convicted West Palm Beach retina surgeon Solomon Melgen, MD, on 67 counts of Medicare fraud. This high-profile case hit very close to home, as myself and another retina specialist from my own community were on opposing sides of the case.
Genetic testing initiative for inherited retinal diseases shows great promiseI have been encouraged as a retinal specialist with all the excitement and promising new treatments in gene therapy. Given that there are several retinal diseases with known inherited patterns and confirmed genetic loci responsible for the clinical manifestations, our field is primed to benefit from the expansion of knowledge in this arena.
The Retinator II: Judgment Day?
The Retinator II: Judgment Day?Hollywood loves trilogies, and though not all sequels are created equal, as a general rule, the second installment tends to be the best. The examples of this phenomenon are numerous (Godfather Part II, Back to the Future II, The Empire Strikes Back, etc.). However, the most-cultured Ophthalmology Times readers will no doubt point to Terminator II as the best example of all.
The secret to reducing staff turnoverIs staff turnover holding you back? In some markets, healthcare personnel turnover is five times higher than unemployment. The average total turnover rate reported for healthcare employers in 2016 is 20.1%, up from 19.2% in 2015, according to Compdata Surveys’ national survey, Compensation Data Healthcare.
New paradigm shift in selecting a steroid course prior to FAc implantAs retinal specialists, we are truly fortunate to live in a time where we have several treatment options for patients with diabetic macular edema (DME). A fluocinolone acetonide (FAc) intravitreal implant 0.19 mg (Iluvien, Alimera Sciences) is indicated for the treatment of DME in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in IOP.
How conference attendance benefits your teamAre you planning on going to a conference this year? As Howard Schultz, chairman and chief executive officer of Starbucks, summarized, knowledge and skill are your keys to earning more. Professional conference season is upon us. Which ones are you paying for you and your employees to attend? No matter how dedicated and organized your practice may be, it’s impossible to internally train each and every staff member to the high level of excellence your patients demand. Thoughtfully motivating and engaging employees takes a concerted and systemic approach to learning and skills training.
How to run the best possible practice in 2017I see the beginning of 2017 as fresh. A year of fresh possibilities. It is new and brimming with fresh beginnings, filled with hopes and dreams. If you are not feeling it, perhaps you are ensnared in the gray world of A, B, and C. This ABC is a continuous loop. You are not sure how you got there or how to get out.
Find your Leadership Compass and reclaim your authority to leadHave you lost your practice’s core values—that spark that made you excited to come to work every day? A lot of managers have lost their leadership compass—their core values—and aren’t making strategic decisions.
What ophthalmologists are thankful for
What ophthalmologists are thankful forAs we sit down together with our families and friends for Thanksgiving dinner this year, we thought reflecting on the great innovations in the field of ophthalmology since the turn of this new century seemed timely (a topic that is a natural by-product of the marriage between a retinal surgeon and a pediatric ophthalmologist!).